How to solve α compound problem.
Creating a pipeline of compounds with the greatest chance of therapeutic efficacy and commercial success is the ultimate goal in drug discovery and development. However, promising lead candidates often fail late in the process, sending your team back to square one. We've all learned that ADME/Tox deficiencies are a major cause of such failures, killing a promising compound in development, or worse, post launch. Camitro has created an integrated suite of pre dictive models that can identify ADME/Tox properties at the beginning of the drug discovery process. Our technology analyzes each molecule to predict metabolism, absorption, and other ADME/Tox properties, making it possible to simulate, visualize, and optimize multiple properties simultaneously—oil based upon chemical structure alone.
Camitro Corporation, 4 0 4 0 Campbell Avenue, Menlo Park, CA 9 4 0 2 5 Camitro is a wholly owned subsidiary of ArQule, Inc.
One example is Metabolic LandscapeSM analysis, where scientists can view the lability of all potential sites of metabolism on a compound, thus facilitating the selection and redesign of a promising candidate. By designing and selecting candidates with optimal ADME/Tox profiles early, resources can be focused on developing compounds that have the greatest chance of success and avoiding those likely to fail. Create high quality, best-in-class medicines. Let Camitro solve your compound problem.
Camitro ...optimizing
650.614.7018
lead
discovery
Fax: 6 5 0 . 3 2 7 . 4 6 3 9 w w w . c a m i t r o . c o m
